Figure 1From: Rivaroxaban versus enoxaparin/vitamin K antagonist therapy in patients with venous thromboembolism and renal impairmentRecurrent VTE and bleeding in relation to renal function across the entire analysis period. EINSTEIN DVT and EINSTEIN PE patients. VKA, vitamin K antagonist; VTE, venous thromboembolism.Back to article page